Valuation : Amphastar Pharmaceuticals, Inc.

Market Cap 94Cr 81Cr 76Cr 69Cr 130.08Cr 8.95TCr 130.5Cr 897.45Cr 350.15Cr 4.52TCr 351.52Cr 343.87Cr 15TCr P/E 2026 *
10.1x
P/E 2027 * 8.34x
Enterprise Value 123.97Cr 106.82Cr 100.16Cr 91Cr 172.24Cr 12TCr 172.79Cr 1.19TCr 463.63Cr 5.98TCr 465.44Cr 455.31Cr 20TCr EV / Sales 2026 *
1.66x
EV / Sales 2027 * 1.43x
Free-Float
47.23%
Yield 2026 *
-
Yield 2027 * -
1 day+0.59%
1 week+1.90%
Current month+10.38%
1 month+9.23%
3 months+14.04%
6 months+8.80%
Current year-17.81%
1 week 21.26
Extreme 21.2601
22.44
1 month 19.55
Extreme 19.55
22.64
Current year 16.64
Extreme 16.645
29.52
1 year 16.64
Extreme 16.645
31.26
3 years 16.64
Extreme 16.645
65.92
5 years 16.64
Extreme 16.645
67.66
10 years 12.05
Extreme 12.05
67.66
Manager TitleAgeSince
Chief Executive Officer 79 29/02/1996
Chief Operating Officer 76 29/02/1996
Director of Finance/CFO 58 01/04/2014
Director TitleAgeSince
Chairman 76 29/02/1996
Director/Board Member 79 29/02/1996
Director/Board Member 58 04/08/2022
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Sell

Director

-7,973 0.0181%
07/08/26 Fiscal year

Chief Financial Officer

18,286 0.0415%
09/07/26 Free

Director

24,532 0.0556%
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+1.90%-27.26%-58.43% 94Cr
-0.13%-6.44%+60.47%+112.05% 1,04700Cr
+0.85%-0.81%+52.77%+63.15% 65TCr
-1.03%-3.58%+22.87%+73.29% 45TCr
-1.46%-4.50%+37.43%+38.41% 35TCr
-0.72%-2.89%+21.86%+36.79% 29TCr
-1.19%-2.21%+1.35%+12.29% 25TCr
-1.05%-1.57%+51.40%+68.55% 23TCr
+0.08%-1.78%-17.64%-54.29% 20TCr
-2.14%-0.30%+29.42%+89.10% 18TCr
Average -0.63%-2.22%+23.27%+38.09% 36.6TCr
Weighted average by Cap. -0.48%-3.46%+38.64%+65.48%

Financials

2026 *2027 *
Net sales 75Cr 64Cr 60Cr 55Cr 103.89Cr 7.15TCr 104.22Cr 716.75Cr 279.65Cr 3.61TCr 280.74Cr 274.63Cr 12TCr 78Cr 68Cr 63Cr 58Cr 108.98Cr 7.5TCr 109.33Cr 751.89Cr 293.36Cr 3.78TCr 294.51Cr 288.1Cr 13TCr
Net income 9.93Cr 8.56Cr 8.02Cr 7.32Cr 14Cr 949.23Cr 14Cr 95Cr 37Cr 479.17Cr 37Cr 36Cr 1.59TCr 12Cr 9.95Cr 9.33Cr 8.51Cr 16Cr 1.1TCr 16Cr 110.64Cr 43Cr 556.85Cr 43Cr 42Cr 1.85TCr
Net Debt 30Cr 26Cr 25Cr 22Cr 42Cr 2.9TCr 42Cr 290.84Cr 113.48Cr 1.46TCr 113.92Cr 111.44Cr 4.85TCr 18Cr 16Cr 15Cr 14Cr 26Cr 1.76TCr 26Cr 176.5Cr 69Cr 888.38Cr 69Cr 68Cr 2.95TCr
Logo Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells active pharmaceutical ingredient (API) products. Most of the Company's finished products are contracted and distributed through group purchasing organizations, drug wholesalers, and drug retailers. The Company manufactures and sells over 25 prescription pharmaceutical products, and one over-the-counter product, Primatene MIST. Its marketed products include BAQSIMI (glucagon) nasal powder 3mg, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone, Cortrosyn, Amphadase, and Epinephrine injection. It manufactures and sells two API products: Recombinant Human Insulin (RHI API) and porcine insulin API. It is also focused on generic and proprietary product candidates in the injectable, inhalable, topical, and intranasal markets.
Employees
1,976
Date Price Change Volume
28/26/28 $22.01 +0.59% 2,24,533
27/26/27 $21.88 -0.64% 2,59,787
26/26/26 $22.02 +0.18% 3,95,610
25/26/25 $21.98 +2.14% 2,83,774
24/26/24 $21.52 -0.37% 2,10,263
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
22.01USD
Average target price
22.50USD
Spread / Average Target
+2.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMPH Stock